A practical reference on anti-doping: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-31 and is reviewed periodically as new material appears.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
Under this state, there was great religious freedom, and alongside the Norman nobles existed a meritocratic bureaucracy of Jews, Muslims and Christians, both Catholic and Eastern Orthodox. The Kingdom of Sicily thus became characterized by Norman, Byzantine, Greek, Arab, Lombard and "native" Sicilian populations living in harmony, and its Norman rulers fostered plans of establishing an empire that would have encompassed Fatimid Egypt as well as the crusader states in the Levant. One of the great geographical treatises of the Middle Ages, the "Tabula Rogeriana", was written by al-Idrisi for King Roger II of Sicily, and entitled "Kitab Rudjdjar" ("The Book of Roger").
=== Toxicity === Although selenium is an essential trace element, it is toxic if taken in excess. Exceeding the Tolerable Upper Intake Level of 400 micrograms per day can lead to selenosis. This 400 microgram (μg) Tolerable Upper Intake Level is based primarily on a 1986 study of five Chinese patients who exhibited overt signs of selenosis and a follow-up study on the same five people in 1992. The 1992 study actually found the maximum safe dietary Se intake to be approximately 800 micrograms per day (15 micrograms per kilogram body weight), but suggested 400 micrograms per day to not only avoid toxicity, but also to avoid creating an imbalance of nutrients in the diet and to account for data from other countries. In China, people who ingested corn grown in extremely selenium-rich stony coal (carbonaceous shale) have suffered from selenium toxicity. This coal was shown to have selenium content as high as 9.1%, the highest concentration in coal ever recorded in literature. Symptoms of selenosis include a garlic odor on the breath, gastrointestinal disorders, hair loss, sloughing of nails, fatigue, irritability, and neurological damage. Extreme cases of selenosis can result in cirrhosis of the liver, pulmonary edema, and death. Elemental selenium and most metallic selenides have relatively low toxicities because of their low bioavailability. By contrast, selenates and selenites are very toxic, having an oxidant mode of action similar to that of arsenic trioxide. The chronic toxic dose of selenite for humans is about 2400 to 3000 micrograms of selenium per day for a long time.
Gabapentinoids, also known as α2δ subunit-containing voltage-gated calcium channel ligands, include drugs like gabapentin, pregabalin, and gabapentin enacarbil. They have been found to increase slow wave sleep (deep sleep) in people with insomnia and healthy individuals. However, they do not appear to improve sleep onset. The gabapentinoid atagabalin (PD-0200390) was under formal development for treatment of insomnia, but development was discontinued following unsatisfactory clinical trial results. PD-0299685 is another gabapentinoid that was under development for the treatment of insomnia, specifically that related to menopausal symptoms, but its development was discontinued similarly.
== External links == Homepage of the Mann department at the MPI of Biochemistry Nature article about the Novo Nordisk Foundation Center for Protein Research Denmark launches big push for protein power
Sources: en.wikipedia.org
In Köppen climate classification the regions of India are: Dry-winter, humid sub-tropical (CWa, largely the river plains of the Ganges, Brahmaputra, and Punjab rivers); Tropical savanna with dry winters (Aw, large parts of peninsular India except the Deccan Plateau and the Western Ghats); Hot semi-arid (BSh, Deccan plateau, parts of Gujarat, eastern Rajasthan, Punjab, and Western Uttar Pradesh); Hot Desert (BWh, northern Gujarat and western Rajasthan); Tropical Monsoon (Am, Western Ghats), Dry winter sub-topical highland (CWb, Himachal Pradesh, Uttarakhand, northern Bengal and upper northeast India), Cold desert (BWk, Eastern Ladakh), Tropical rainforest (Af, Sundarbans, Andaman and Nicobar Islands; Warm summer hemiboreal (Dsb, upper Himachal Pradesh and Kashmir below the Himalayas), and Ice cap in the Western Himalayas. Monsoon weather systems play a significant role in India's climate. In turn, the Himalayas and the Tibetan Plateau play an important role in creating the South Asian monsoon, which accounts for 75 to 80 per cent of India's annual rain. In winter, the Tibetan Plateau (average altitude 4500 m) acts like a tower of ice and splits the westerlies, both the low-level and, by friction, the high-altitude jet streams. The southern branch rounds the Himalayas. Just beyond, as it slows down and creates a convergence, or backup, the air sinks, creating dry, northeasterly surface winds over India. This maintains dry, cool, Indian winters.
== Career == On 18 July 1985, he co-founded the Belgian biotech company Innogenetics, together with Erik Tambuyzer and Hugo Van Heuverswyn and has been its chairman since then. Besides Innogenetics, he founded several clinical laboratories. He is an international centralized clinical laboratory. He is also CEO of Gengest BVBA (management company), Biovest CVA, LMA BVBA, Laboraco BVBA, and he is director of DSJ Bruxelles NV and Oystershell NV. Rudi Mariën is a member of the American Association for Clinical Chemistry.
== Matrix-assisted laser desorption/ionization == MALDI is an ionization technique where laser energy is absorbed by a matrix to create ions from large molecules without fragmentation. The matrix, typically in excess, is mixed with the analyte molecule and deposited on a target. A table of matrix compounds, their structures, laser wavelengths typically used, and typical application is shown below.
Sources: en.wikipedia.org
Silanization is the attachment of an organosilyl group to some chemical species. Almost always, silanization is the conversion of a silanol-terminated surface to an alkylsiloxy-terminated surface. This conversion confers hydrophobicity to a previously hydrophilic surface. This process is often used to modify the surface properties of glass, silicon, alumina, quartz, and metal oxide substrates, which all have an abundance of hydroxyl groups. Silanization differs from silylation, which usually refers to attachment of organosilicon groups to molecular substrates.
== I == ichthyology – immune cell – immune system – immunology – inbreeding – inducibility – infectious disease carrier – infertility – inner matrix – insect – insectivores – insulin – intermediate filament – intermembrane space – interphase – intestine – intron – invasive species – ion channel – isoenzyme – isotonic (exercise physiology)
In March 2010, the Center for Public Integrity released a report that Bush's administration had made more than 900 false pretenses in a two-year period about the alleged threat of Iraq against the United States, as his rationale to engage in war in Iraq.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.